This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Valio Ltd.. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Matti Kankainen: Innovator in Peptide Technology
Introduction
Matti Kankainen is a notable inventor based in Helsinki, Finland. He has made significant contributions to the fields of life sciences and the food, feed, and pharmaceutical industries. His innovative work focuses on novel peptides and methods for producing them.
Latest Patents
Matti Kankainen holds a patent for "Peptides and methods for producing them." This invention relates to various applications, including the development of novel peptides, pilus structures, polynucleotides, and vectors. The patent also encompasses host cells, products, and pharmaceutical compositions that include these components. Furthermore, it details methods for producing peptides or pilus structures and their applications in treating and screening bacterial strains. The invention aims to reduce or inhibit the adhesion of pathogenic bacteria while promoting the adhesion of beneficial bacterial cells to mucus. Additionally, it addresses methods for detecting probiotic bacterial strains or pathogen strains.
Career Highlights
Throughout his career, Matti Kankainen has worked with prominent companies such as Valio Ltd. and Chr. Hansen A/S. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in the industry.
Collaborations
Matti has collaborated with esteemed colleagues, including Willem Meindert De Vos and Airi Palva. These partnerships have further enriched his research and development efforts in peptide technology.
Conclusion
Matti Kankainen is a distinguished inventor whose work in peptide technology has the potential to impact various industries significantly. His innovative approaches and collaborations continue to drive advancements in life sciences and related fields.